Pneumonia
RecruitingStudy on Ceftriaxone Dosing for Patients with Severe Community-Acquired Pneumonia
- Disease:Pneumonia
- Substances:Ceftriaxone
Belgium- Participants:18–64 years · 65+ years
- Substances:Ceftriaxone
- Sponsor:UZ Leuven
Rare diseases
Investigational molecules
Locations
Back to Belgium215 clinical trials in Brugge, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on viral infections and preventive measures, including trials evaluating new vaccines against influenza and cytomegalovirus. Research also covers treatment approaches for hepatitis B and invasive fungal infections.
Innovative approaches in vaccine development and antimicrobial therapies are being tested to combat various infectious diseases.
Comprehensive research into blood cancers and solid tumors, including studies on multiple myeloma, leukemia, and gastric cancer. Novel therapeutic approaches combine targeted treatments with immunotherapy.
Advanced treatment protocols are being evaluated to improve patient outcomes in various cancer types.
Studies addressing cardiovascular disease, obesity, and type 2 diabetes. Research focuses on innovative treatments and prevention strategies for major cardiovascular events.
Trials aim to improve cardiovascular outcomes and metabolic health through novel therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.